Trial Profile
Efficacy of dimethyl fumarate in patients with relapsing-remitting multiple-sclerosis after natalizumab discontinuation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 18 Nov 2016 New trial record